Together, these results suggest that MEAO attenuated ER stress and ameliorated hepatic steatosis via the downregulation of VLDLR expression, and the improvement of ApoB secretion under conditions of suppressed lipogenesis. The gene discussed is APOB; the disease is Hepatic steatosis.